Navigation Links
CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
Date:6/23/2008

1 million people in the United States have chronic angina, and 500,000 new cases are diagnosed annually, according to the American Heart Association.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved products in the United States include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to research and development and commercialization of products, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including operating losses and fluctuations in operating results; capital requirements; regulatory review and approval of our products; special protocol assessment agreement; the conduct and timing of clinical trials; commercialization of products; market acceptance of products; product labeling; concentrated customer base; reliance on strategic partnerships and collaborations; uncertainties in drug development; uncertainties regarding intellectual property and other risks detailed from time to time in CV Therapeutics' SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. CV Therapeutics disclaims any
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
2. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
3. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
4. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
5. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
6. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
11. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Soligenix, Inc. (OT..., formerly known as DOR BioPharma, Inc., a late-st... has formed a consortium to develop thermostable t...cting vaccines. Soligenix received a $9.4 million ...nfectious Diseases (NIAID), a division of the Nati...
(Date:11/19/2009)... In response to an ever-increasing ... medicines, Operation Pangea II, involving 24 coun...ealth Organization,s International Medical Product...ght the dangers of buying medicines online. ,, ...es of arrests and the seizure of thousands of pote...
(Date:11/19/2009)... Nov. 19 Alexza Pharmace...t its corporate presentation will be webcast live ...onference on Wednesday, December 2, 2009 at 9:00 a...t from The New York Palace Hotel in New York and w...nt and CEO. ,, To access the live presentatio...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Statement From Stuart L Weinstein MD Chairman Doctors for Medical Liability Reform on Senator Baucus Health Care Reform Proposal 57662 1Statement From Stuart L Weinstein MD Chairman Doctors for Medical Liability Reform on Senator Baucus Health Care Reform Proposal 57662 2John J Young Jr Joins SRI Board of Directors 14149 1John J Young Jr Joins SRI Board of Directors 14149 2John J Young Jr Joins SRI Board of Directors 14149 3Back To School and Back To Important Health Basics For Youth 57659 1Back To School and Back To Important Health Basics For Youth 57659 2Back To School and Back To Important Health Basics For Youth 57659 3
...Ventilator Clinical Trials Also Underw...Biomedical Inc., (http://www.synapsebiomedical.com...he U.S. Food and Drug Administration (FDA) for its...d Injury (SCI) patients who lack voluntary,control... patients and,their caregivers throughout the U.S....
...oma,Society (LLS) and Memgen jointly announced an ...inical trial. The trial will use Memgen,s,ISF35, a...ic lymphocytic,leukemia (CLL)., Based on its alli...nical trial this year for up to 12 patients who ha...therapeutic options. Patients will receive three,i...
Other Medicine Technology:Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 2Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 4Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 5Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 6The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 3
(Date:11/22/2009)... Man & Machine post You Tube video demo...etition , Landover, MD (P... interested in learning what a really rugged water...quo;Really Cool Keyboard vs Washable Competitors K...monstrates how the premium, Really Cool Keyboard f...
(Date:11/21/2009)...GTON, Nov. 21 Tonight, ...ed to Senator Reid,s version of the government tak...ble items included in this bill; like the public o...vernment funding for elective abortion, which is t...nally the bill provides subsidies for private plan...
(Date:11/21/2009)...his bill provides for an unprecedented expansion o...bout if it is not for preserving and protecting hu...efeated." Charmaine Yoest ,, WASHINGTON, Nov...or Life Action President and CEO Dr. Charmaine Yoe...leasing the following statement: ,, "This was ...
(Date:11/21/2009)...NGTON, Nov. 21 A region...nchocerciasis (river blindness) in the Americas ha...ase in recent years, as evidenced by a 31% decreas... administration in six endemic countries. Results... the American Society of Tropical Medicine and Hyg...
(Date:11/21/2009)...ON, November 21, 2009 Te...st Test Test Test Test Test Test Test Test,Test Te...st Test Test Test,Test Test Test Test Test Test Te...ore test More test More test More test More test M...ore test More test More test More,test More test ,...
Breaking Medicine News(10 mins):Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4
...at Cornell University have discovered how a fish f... // sounds at the same time!!. In an endea...imes lead scientist to look the way animals of dif...ientists have found that there exists a direct lin...
...e in the recent issue of the journal Thorax, resea...B and smoking. Researchers have looked into t...o establish a firm connection between smoking and ... that the increase of the risk of acquiring Mycoba...
...ays been looked at by outsiders as the land of mys... harmonious central key to getting in touch with t...ore to this large sub-continent then what meets th...r in Asia every day. 1,500 persons effected with t...
... Food and Drug Administration (FDA) issued a publi...re // providers about the suspended marketing of T...sing forms of multiple sclerosis (MS) which was ap... trials. However, it is believed that the drug has...
...dy can release chemical compounds like marijuana t... of pain from severe trauma // like accidents. ... like wounds from gun shot, or accidents causing s...n for sometime. Scientists working for Univer...
...from University of Michigan, who had long earlier .../ snoring in childhood and having ADHD, have come ...y that conclusively links the association between ...od are four times as likely to have hyperactivity ...
Other Medicine News:Health News:AIDS - The ‘silent but lethal tsunami’ of Asia 2
Bipolar Bayonet Forceps
Elmed Extra Long Straight Bipolar Forceps
Micro Forceps
Bi-Co-Matic Handswitching Bipolar Micro Forceps with Elmed Fitting, Insulated
Medicine Products: